1. Market Research
  2. > Neorphys - Product Pipeline Review - 2013

Neorphys - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 23 pages

Neorphys - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Neorphys - Product Pipeline Review - 2013” provides data on the Neorphys’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Neorphys’s corporate website, SEC filings, investor presentations and featured press releases, both from Neorphys and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Neorphys - Brief Neorphys overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neorphys human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neorphys with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neorphys’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Neorphys’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neorphys in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neorphys’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neorphys.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neorphys and identify potential opportunities in those areas.

Table Of Contents

Neorphys - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Neorphys Snapshot 4
Neorphys Overview 4
Key Information 4
Key Facts 4
Neorphys - Research and Development Overview 5
Key Therapeutic Areas 5
Neorphys - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Neorphys - Pipeline Products Glance 9
Neorphys - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Neorphys - Drug Profiles 11
Neo-1507 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Neo-1509 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Neo-1528 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Neo-15xx 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Neorphys - Pipeline Analysis 15
Neorphys - Pipeline Products by Therapeutic Class 15
Neorphys - Pipeline Products by Target 16
Neorphys - Pipeline Products by Route of Administration 17
Neorphys - Pipeline Products by Molecule Type 18
Neorphys - Pipeline Products by Mechanism of Action 19
Neorphys - Dormant Projects 20
Neorphys - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23



List of Tables

Neorphys, Key Information 4
Neorphys, Key Facts 4
Neorphys - Pipeline by Indication, 2013 6
Neorphys - Pipeline by Stage of Development, 2013 7
Neorphys - Monotherapy Products in Pipeline, 2013 8
Neorphys - Preclinical, 2013 9
Neorphys - Discovery, 2013 10
Neorphys - Pipeline by Therapeutic Class, 2013 15
Neorphys - Pipeline by Target, 2013 16
Neorphys - Pipeline by Route of Administration, 2013 17
Neorphys - Pipeline by Molecule Type, 2013 18
Neorphys - Pipeline Products by Mechanism of Action, 2013 19
Neorphys - Dormant Developmental Projects,2013 20



List of Figures

Neorphys - Pipeline by Top 10 Indication, 2013 6
Neorphys - Pipeline by Stage of Development, 2013 7
Neorphys - Monotherapy Products in Pipeline, 2013 8
Neorphys - Pipeline by Top 10 Therapeutic Class, 2013 15
Neorphys - Pipeline by Top 10 Target, 2013 16
Neorphys - Pipeline by Top 10 Route of Administration, 2013 17
Neorphys - Pipeline by Top 10 Molecule Type, 2013 18
Neorphys - Pipeline Products by Top 10 Mechanism of Action, 2013 19



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.